We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Europe

News List

Vifor’s hyperkalaemia drug Veltassa approved in Europe pharmaphorum
July 24, 2017
Vifor Pharma has gained final European marketing approval for its hyperkalaemia treatment Veltassa.
Biosimilar medicines: Dramatic increase in patient access across Europe europeanpharmaceuticalreview
May 26, 2017
Biosimilar medicines have dramatically increased patient access to biological medicines, according to the recently published QuintilesIMS report on ‘The impact of biosimilar competition in Europe’.
Ensuring Universal Access is a Political Choice lilly
May 18, 2017
In the spirit of open debate, this blog represents the views of its author and her organization, EPF.

Previous page 1 2 3 4 5 Next page